Abstract |
The allergen challenge has evolved, in less than 150 years, from a crude tool used to document the etiology of allergen-induced disease to a well-controlled tool used today to investigate the pathophysiology and pharmacotherapy of asthma. Highlights of the authors' involvement with the allergen challenge include confirmation of the immunoglobulin E-dependence of the late asthmatic response, importance of (nonallergic) airway hyper-responsiveness as a determinant of the airway response to allergen, identification of allergen-induced increase in airway hyper-responsiveness, documentation of beta(2)-agonist-induced increase in airway response to allergen (including eosinophilic inflammation), advances in understanding the pathophysiology and kinetics of allergen-induced airway responses, and development of a multicentre clinical trial group devoted to using the allergen challenge for investigating promising new therapeutic strategies for asthma.
|
Authors | Donald W Cockcroft, Fredrick E Hargreave, Paul M O'Byrne, Louis-Philippe Boulet |
Journal | Canadian respiratory journal
(Can Respir J)
Vol. 14
Issue 7
Pg. 414-8
(Oct 2007)
ISSN: 1198-2241 [Print] Egypt |
PMID | 17948142
(Publication Type: Historical Article, Journal Article, Review)
|
Chemical References |
- Allergens
- Immunoglobulin E
|
Topics |
- Allergens
(adverse effects, immunology)
- Asthma
(history, immunology)
- Bronchial Provocation Tests
(history, methods)
- Canada
- History, 19th Century
- History, 20th Century
- History, 21st Century
- Humans
- Hypersensitivity
(immunology, physiopathology)
- Immunoglobulin E
(immunology)
|